Sanofi-Aventis May Raise $18.5 Billion Cash Bid For Genzyme [Getty Images]

Pills of Sanofi-Aventis SA's insomnia medicine Ambien are arranged for a photo at New London Pharmacy in New York, U.S., on Tuesday, Aug. 31, 2010. Sanofi-Aventis SA, France's biggest drugmaker, indicated it may raise its $18.5 billion cash bid for Genzyme Corp., the world's largest maker of medicines for genetic diseases, if Genzyme's management would come to the negotiating table. Photographer: JB Reed/Bloomberg via Getty Images

Bloomberg Bloomberg